🇺🇸 FDA

Intelligence Platform

Patents

Browse 8 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11197844

Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancre

The Regents of the University of California · Granted Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10813909

Triple drug combination (metformin, simvastatin, digoxin) for targeted treatment of pancre

The Regents of the University of California · Granted Tue Oct 27 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 22 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10668021

Metformin hydrochloride osmotic pump tablet and preparation method therefor

ELITE PHARMA TECHNOLOGY (SHANGHAI) CO., LTD. · Granted Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 28 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10363244

Compositions comprising metformin and a glucokinase activator

VTV THERAPEUTICS LLC · Granted Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10064846

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC · Granted Tue Sep 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 30 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9855251

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC · Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9359313

Use of metformin in combination with a glucokinase activator and compositions comprising m

VTV THERAPEUTICS LLC · Granted Tue Jun 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 02 2036 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8900638

Solid preparation comprising alogliptin and metformin hydrochloride

Takeda Pharmaceutical Company Limited · Granted Tue Dec 02 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted